Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Dr. Claire de la Calle

๐Ÿ‘ค Speaker
340 total appearances

Appearances Over Time

Podcast Appearances

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

You can have a PI-RADS 5 patient get downgraded to PI-RADS 2.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And so maybe AI will help limit those misclassifications on MRI.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And actually going back to digital pathology one more time, there are also a lot of pretty reliable algorithms for simple Gleason scoring, which I think, you know, obviously is not as exciting as a MMI type tool that predicts progression or some other oncologic outcome.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

But we, you know, you and I, we both work in academic centers, so we're very lucky to work with GU pathologists.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

But having access to a GU pathologist through an AI algorithm, I think, is very exciting.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And several studies have shown that these AI reads can provide reads that are at the level of a GU pathologist.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And so I think that'll be really important for Actis as well.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Yeah, great points.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

I mean, exactly like you said it, it's considered currently an option for intermediate-risk patients, unlike low-risk, where active surveillance is clearly stated in our guidelines as the preferred option.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

So as of right now, for intermediate-risk patients, it's just an option.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

I think it's important for the patient to know that they can't go wrong.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

No one will fault them or the provider for choosing active surveillance over active treatment.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And I think that's really important, especially for the very anxious, the anxious patient.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Then in terms of active surveillance, I think it's important to counsel them on their risk of progression and just overall oncologic outcomes that they can get.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

And if they have any of those risk factors that we mentioned earlier that potentially makes them a borderline active surveillance patient, they really need to understand and

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

that the risk is going to be higher than the average active surveillance patient.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Yeah.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Now, I don't tell them that that means they can't do active surveillance.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Sometimes I'll frame it as, well, it's not really a matter of if we're going to do treatment, but when we're going to do treatment.

BackTable Urology
Ep. 288 Active Surveillance for Intermediate Risk Prostate Cancer with Dr. Claire de la Calle

Because any time on active surveillance, in my mind, is a win.